ClinicalTrials.Veeva

Menu

Pre Transplantation Melanoma (MPG)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Malignant Melanoma

Treatments

Other: patient with melanoma pre transplantation

Study type

Observational

Funder types

Other

Identifiers

NCT04217382
69HCL19_0636

Details and patient eligibility

About

Melanoma incidence is increase in global population and number of transplantation also. However immunosuppressor increase recurrence risk of melanoma.

There are more and more cases of eligible patients to transplant with an antecedent of melanoma. There is no guideline yet.

Main objective is survival time without melanoma recurrence in this population to do guideline of time limit or not between melanoma and transplantation by stage.

Enrollment

37 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient with an antecedent of melanoma before transplantation
  • Not opposite to participate

Exclusion criteria

  • Under the age of 18
  • patient under Guardianship
  • patient not affiliated with a health system

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems